Abstract
Solid organ transplant recipients are at an elevated risk of severe coronavirus disease 2019 (COVID-19), and early reports also suggest impaired response after the first dose of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine series.1–3 Because of concerns about vaccine immunogenicity, all kidney transplant recipients at our center are recommended to undergo anti–SARS-CoV-2 spike protein IgG (“anti-spike antibody”) testing 2 to 6 weeks after completing their vaccination series in full.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
